1. Anthropic's 1M Context Window Is Now Free to Use
    Technology

    Anthropic's 1M Context Window Is Now Free to Use

    Anthropic just killed the surcharge on its 1M token context window — a 900K-token request now costs the same per token as a 9K one. Flat pricing, live today across Claude Platform, Azure, and Vertex AI.

    ·1 min read
  2. OpenAI Is Folding Sora Into ChatGPT
    Technology

    OpenAI Is Folding Sora Into ChatGPT

    Sora dropped out of Apple's top 100 apps by February — just weeks after launch. OpenAI's fix: fold it into ChatGPT, where hundreds of millions of users already live.

    ·1 min read
  3. Meta Bought Moltbook, a Social Network for Robots
    Technology

    Meta Bought Moltbook, a Social Network for Robots

    Moltbook hit millions of registered bots within days of launch — then Meta bought it. The acquisition reveals how seriously Big Tech is investing in AI-to-AI communication infrastructure.

    ·1 min read
  4. Nvidia Just Invested $2 Billion to Build the Distribution Channel for Its Own Chips
    Technology

    Nvidia Just Invested $2 Billion to Build the Distribution Channel for Its Own Chips

    Nvidia just bought an 8.3% stake in Amsterdam-based Nebius for $2 billion — a calculated bet on the neocloud layer sitting between hyperscalers and enterprise AI buyers.

    ·1 min read
  5. How Uristocrats Can Own the AI Infrastructure Boom
    Technology

    How Uristocrats Can Own the AI Infrastructure Boom

    The real AI infrastructure bet isn't that AI gets big — the market already priced that in. It's that the physical and electrical buildout cycle is longer and more capital-intensive than current valuations reflect.

    ·6 min read
  6. The Intelligence Premium Is Narrowing. Here's What That Means for You.
    Technology

    The Intelligence Premium Is Narrowing. Here's What That Means for You.

    A Citrini Research thought experiment about AI wiping out white-collar work went viral on finance Twitter — and briefly moved markets. Here's what the Intelligence Displacement Spiral means for the top 20%.

    ·6 min read
  7. Apple Podcasts Is Going Video — Here's What It Means for DJs and Creators
    Technology

    Apple Podcasts Is Going Video — Here's What It Means for DJs and Creators

    Apple Podcasts is collapsing the audio/video split with HLS streaming — one feed, offline downloads, and dynamic video ad insertion. For DJs, it's finally one platform to rule them all.

    ·2 min read
  8. Daily Roundup: February 20, 2026
    Daily Roundup

    Daily Roundup: February 20, 2026

    Jaylen Brown posted 23 points, 15 rebounds, and 13 assists as Boston reasserted itself post-All-Star break. On shelves today: Vans x OAMC, Reebok Angel Reese 1 Muted Mauve, and the Naruto Chuck Taylor trio.

    ·5 min read
  9. RentAHuman.ai Launches Platform for AI Agents to Hire Humans for Physical Tasks
    Technology

    RentAHuman.ai Launches Platform for AI Agents to Hire Humans for Physical Tasks

    RentAHuman.ai flips automation on its head — AI agents can now hire humans to touch grass on their behalf, paying in stablecoins for errands, installs, and real-world tasks.

    ·1 min read
  10. Daily Roundup: February 4, 2026
    Daily Roundup

    Daily Roundup: February 4, 2026

    James Harden heads to Cleveland for Darius Garland as the NBA trade deadline looms, while Nike's Kobe 1 Protro 'Work Blue' hits shelves at $210 — part of a coordinated All-Star Week sneaker push.

    ·3 min read
  11. Anthropic Doubles Fundraising Target to $20 Billion at $350 Billion Valuation
    Technology

    Anthropic Doubles Fundraising Target to $20 Billion at $350 Billion Valuation

    Anthropic nearly doubled its valuation to $350 billion after strong investor demand pushed its fundraising target from $10B to $20B — with backers like Sequoia and Amazon lining up as an IPO looms.

    ·1 min read
  12. First Human Test of Cellular Rejuvenation Method to Begin Shortly
    Science

    First Human Test of Cellular Rejuvenation Method to Begin Shortly

    Harvard's David Sinclair co-founded Life Biosciences to bring age-reversing cellular reprogramming from mice to humans — and the first FDA-approved trial is nearly here.

    ·1 min read